Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-03-26 to 2025-03-27
Current total value of award: $5019.01
Description: 4567702241!QUILLIVANT XR ORAL SUSP 180ML 5MG/ML